Anti-CD20 (Ibritumomab), Humanized Antibody

Anti-CD20 (Ibritumomab), Humanized Antibodyis available at Gentaur for Next week Delivery.

Description: This research-grade biosimilar is a monoclonal antibody with a human IgG2A backbone fused to the antigen-binding domain and targets CD20, a surface antigen found on B lymphocytes. Binding of the CD20 surface antigen has been shown to induce apoptosis in B lymphocytes in vitro. The humanized anti-CD20 antibody, in concert with a carrier, acts as a delivery system for radioimmunotherapy against B cell lymphoma.

Immunogen Sequence:FAUX

Target Alternative Name:B1; S7; Bp35; CD20; CVID5; MS4A1; LEU-16

Species Reactivities:Human

Tag Line:A humanized antibody that binds to CD20

Formulation:In PBS pH 7.5

Purification: FAUX

Application:FAUX

Positive Control:/

Application And Usages:/

Handling:The antibody solution should be gently mixed before use.